Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Zevra Therapeutics (ZVRA) Equity Ratio (2016 - 2025)

Historic Equity Ratio for Zevra Therapeutics (ZVRA) over the last 11 years, with Q3 2025 value amounting to 0.49.

  • Zevra Therapeutics' Equity Ratio rose 3534.91% to 0.49 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.49, marking a year-over-year increase of 3534.91%. This contributed to the annual value of 0.22 for FY2024, which is 3796.97% down from last year.
  • Latest data reveals that Zevra Therapeutics reported Equity Ratio of 0.49 as of Q3 2025, which was up 3534.91% from 0.46 recorded in Q2 2025.
  • Zevra Therapeutics' 5-year Equity Ratio high stood at 4.17 for Q2 2023, and its period low was 0.22 during Q4 2024.
  • Over the past 5 years, Zevra Therapeutics' median Equity Ratio value was 0.65 (recorded in 2022), while the average stood at 1.39.
  • Its Equity Ratio has fluctuated over the past 5 years, first skyrocketed by 27903.98% in 2022, then crashed by 9460.15% in 2024.
  • Zevra Therapeutics' Equity Ratio (Quarter) stood at 0.96 in 2021, then tumbled by 31.89% to 0.65 in 2022, then crashed by 44.88% to 0.36 in 2023, then crashed by 37.97% to 0.22 in 2024, then soared by 121.39% to 0.49 in 2025.
  • Its Equity Ratio was 0.49 in Q3 2025, compared to 0.46 in Q2 2025 and 0.24 in Q1 2025.